FDA Inspection 1264006 — Voyant Beauty, Inc.

Voyant Beauty, Inc. — FEI 1000251162

The FDA completed an inspection of Voyant Beauty, Inc. on May 30, 2025 in Etobicoke. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 30, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
180121 CFR 211.84(a)Components withheld from use pending release
360321 CFR 211.160(b)Scientifically sound laboratory controls